FDA Inspection 855749 — ImpactLife

ImpactLife — FEI 3009755290

The FDA completed an inspection of ImpactLife on November 25, 2013 in Saint Peters, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 25, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Saint Peters, MO (United States)